Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation‐Based Biodistribution Studies
Drug Development Research · 2026-04 · 87 (2)
DOI: 10.1002/ddr.70274 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 31.03.2026. Verfasst von Mostafa M Ghorab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Antioxidants, Benzenesulfonamides, NAD(P)H Dehydrogenase (Quinone). Die Arbeit nennt 63 Literaturangaben. Gefördert von: STDF, Cancer Research UK.
Abstract (Originalsprache)
A series of quinazoline derivatives 5–19 bearing a benzenesulfonamide moiety and different acetamide side chains, including aromatic and heterocyclic groups, were designed, synthesized and confirmed structurally by microanalytical and spectral data. The obtained compounds were evaluated in vitro for their ability to activate nuclear factor erythroid 2‐related factor 2 (Nrf2) through induction of NAD(P)H: quinone oxidoreductase 1 (NQO1) in Hepa1c1c7 murine hepatoma cells. Compounds 15 and 18 exhibited the highest potency with CD values of 2.5 and 5 µM, respectively. The most potent derivatives ( 15 and 18 ) were further evaluated for their antioxidant potential using DPPH, with compound 18 demonstrating the highest radical scavenging activity. A radiation‐based biodistribution study was conducted using 18 and displayed marked selectivity toward tumor cells over normal cells. Molecular docking studies and molecular dynamics simulations demonstrated that 18 exhibits a strong binding affinity and forms key stabilizing interactions within the Nrf2‐binding domain of Kelch‐like ECH‐associated protein 1 (Keap1). These results demonstrate that quinazoline sulfonamide derivatives are promising oxidative stress modulators with tumor targeting ability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt.
- Jacqui Wood Cancer Centre, Division of Cancer Research, School of Medicine, University of Dundee, Scotland, UK.
- Department of Pharmacology and Molecular Sciences and Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Labeled Compounds Department, Hot Labs Center, Egyptian Atomic Energy Authority, Cairo, Egypt.
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt.
- Radioactive Isotopes and Generator Department, Hot Labs Center, Egyptian Atomic Energy Authority, Cairo, Egypt.
ORCID-Profile: Aiten M Soliman
Förderung
- STDF
- Cancer Research UK
Zitieren
APA
Ghorab, M. M., Soliman, A. M., Higgins, M., Dinkova-Kostova, A. T., Amin, M. A., Korany, M., Khedr, M. A., & Sakr, T. M. (2026). Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation‐Based Biodistribution Studies. Drug Development Research, 87(2). https://doi.org/10.1002/ddr.70274
Vancouver
Ghorab MM, Soliman AM, Higgins M, Dinkova-Kostova AT, Amin MA, Korany M, et al. Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation‐Based Biodistribution Studies. Drug Development Research. 2026;87(2). doi:10.1002/ddr.70274
BibTeX
@article{Ghorab2026,
author = {Ghorab, Mostafa M and Soliman, Aiten M and Higgins, Maureen and Dinkova-Kostova, Albena T and Amin, Mohamed A and Korany, Mohamed and Khedr, Mohammed A and Sakr, Tamer M},
title = {Novel Antioxidant Quinazoline Sulfonamide Derivatives Acting Through NQO1 Induction and Their Radiation‐Based Biodistribution Studies},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {2},
doi = {10.1002/ddr.70274}
}
EUVIMED